Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) have earned an average rating of “Buy” from the four brokerages that are covering the stock, Marketbeat reports. Four analysts have rated the stock with a buy rating. The average 12 month target price among brokerages that have covered the stock in the last year […]